Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of ALK-Rearranged Lung Cancer

Published:2020-05 Issue:5 Volume:15 Page:752-765
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Arai Sachiko,Takeuchi Shinji,Fukuda Koji,Taniguchi Hirokazu,Nishiyama Akihiro,Tanimoto Azusa,Satouchi Miyako,Yamashita Kaname,Ohtsubo Koshiro,Nanjo Shigeki,Kumagai Toru,Katayama Ryohei,Nishio Makoto,Zheng Mei-mei,Wu Yi-Long,Nishihara Hiroshi,Yamamoto Takushi,Nakada Mitsutoshi,Yano Seiji

Funder

Chugai Pharmaceutical

Boehringer Ingelheim

Novartis

Roche

Pfizer Japan

AstraZeneca

Bristol-Myers Squibb

Ono Pharmaceutical

Novartis Pharmaceutical

MSD

Ignyta

AbbVie

Lilly

Takeda

Fujifilm

Daiichi Sankyo

Pfizer

Taiho Pharmaceutical

Astellas Pharma

Takeda Pharmaceutical

Regeneron Pharmaceuticals

Merck

Boehringer lngelheim

Eli Lilly Japan

JSPS

AMED

Project for Cancer Research and Therapeutic Evolution

Cancer Research Institute

Kanazawa University

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System;Barnholtz-Sloan;J Clin Oncol,2004

2. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

3. Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4 ALK;Shaw;J Clin Oncol,2009

4. Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer;Doebele;Cancer,2012

5. Frequency of brain metastases and multikinase inhibitor outcomes in patients with RET-rearranged lung cancers;Drilon;J Thorac Oncol,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis;npj Precision Oncology;2024-05-28

2. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges;Frontiers in Immunology;2024-04-09

3. Quantification of Cerebrospinal Fluid Tumor DNA in Lung Cancer Patients with Suspected Leptomeningeal Carcinomatosis;2024-01-04

4. Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L);Therapeutic Advances in Medical Oncology;2024-01

5. CAF-released galectin 1 mediates non-cell-autonomous resistance to ceritinib in NSCLC.;2023-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3